DERL1

Chr 8

derlin 1

Also known as: DER-1, DER1, derlin-1

The encoded protein forms channels in the endoplasmic reticulum membrane that retrotranslocate misfolded proteins from the ER lumen to the cytosol for proteasomal degradation, functioning as a key component of the ER-associated degradation (ERAD) pathway. Biallelic mutations cause infantile-onset epileptic encephalopathy with severe developmental delay, microcephaly, and visual impairment, following an autosomal recessive inheritance pattern. The gene shows low constraint against loss-of-function variants, consistent with the recessive disease mechanism.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
3
Pubs (1 yr)
48
P/LP submissions
0%
P/LP missense
0.84
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryDERL1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
48 unique Pathogenic / Likely Pathogenic· 32 VUS of 100 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.84LOEUF
pLI 0.000
Z-score 2.07
OE 0.48 (0.290.84)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.12Z-score
OE missense 0.74 (0.630.86)
104 obs / 141.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.48 (0.290.84)
00.351.4
Missense OE0.74 (0.630.86)
00.61.4
Synonymous OE0.98
01.21.6
LoF obs/exp: 9 / 18.7Missense obs/exp: 104 / 141.5Syn Z: 0.11
DN
0.88top 5%
GOF
0.75top 25%
LOF
0.1895th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic48
VUS32
48
Pathogenic
32
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
48
0
48
Likely Pathogenic
0
0
0
0
0
VUS
0
31
1
0
32
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total03149080

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

DERL1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →